Stay updated on Safety of SNA-120 in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.

Latest updates to the Safety of SNA-120 in Psoriasis Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a new page version. This update reflects metadata changes rather than substantive content changes.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page behavior.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedA new Revision: v3.5.0 was added and the previous Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.4.2. Removed the notice about government funding and the earlier Revision: v3.4.1.SummaryDifference0.4%

- Check92 days agoChange DetectedNotice added: a government-funding lapse advisory appears on the page and the revision is updated to v3.4.1 (previously v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety of SNA-120 in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.